Table 3.
The main results of the research
Variable | PFNA (n = 110) | DHS (n = 112) | P value |
---|---|---|---|
Total complications | 25 | 50 | |
Patients affected | 18 (16.4 %) | 39 (34.8 %) | 0.002 |
Medical complications | 7 | 8 | |
Patients affected | 6 (5.5 %) | 6 (5.4 %) | 0.974 |
Pressure sore | 2 | 3 | |
Pulmonary infection | 1 | 1 | |
Urinary tract infection | 1 | 1 | |
Deep venous thrombosis | 1 | 1 | |
Atrial fibrillation | 1 | 1 | |
Acute renal failure | 0 | 0 | |
Other | 1 | 1 | |
Orthopaedic complications | 18 | 42 | |
Patients affected | 12 (10.9 %) | 33 (29.5 %) | 0.001 |
Periprosthetic fracture | 1 | 5 | |
Femur shaft fracture after implant removed | 3 | 10 | 0.049 |
Prosthetic instability | 1 | 4 | |
limb length discrepancy (>2.5 cm) | 1 | 1 | |
Malunion | 1 | 2 | |
Nonunion | 2 | 4 | |
Cutout | 1 | 3 | |
Abductor tendon deficiency | 3 | 2 | |
Heterotopic ossification | 1 | 2 | |
Intraoperative nerve injury | 1 | 3 | |
Implant failure | 1 | 1 | |
Aseptic loosening | 0 | 1 | |
Periprosthetic infection | 1 | 2 | |
Osteolysis with well-fixed implants | 0 | 1 | |
Wound infection | 1 | 1 | |
Reoperation required in one year follow-up | 0(0.0 %) | 6(5.4 %) | 0.029 |
Reoperation required in two years follow-up | 1(0.9 %) | 4(8.9 %) | 0.035 |
Reoperation required in three years follow-up | 1(1.8 %) | 2(10.7 %) | 0.006 |
Reoperation required in four years follow-up | 3(4.5 %) | 2(12.5 %) | 0.034 |
Reoperation required at last follow-up | 2(6.4 %) | 1(13.4 %) | 0.080 |